Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension

Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.

• Tesamorelin

  Stabilized GHRH analog studied in lipodystrophy and visceral-adiposity research models.
  View product →

• Sermorelin — GHRH (1-29) and the peptide family built on it
  Sermorelin is the unmodified first 29 residues of growth hormone releasing hormone. Every GHRH analog in this market is a modification of it.
  2 min read
• Freeze-thaw cycles and peptide integrity
  Freezing a peptide solution is not free. Each cycle concentrates solutes, shifts pH, and creates ice interfaces — which is why aliquoting beats re-freezing.
  3 min read
• Cold chain and ambient shipping — what actually survives transit
  Lyophilized peptides ship ambient for good reason. Here is the science behind that, and what would genuinely warrant a cold pack.
  3 min read
• CJC-1295 vs Ipamorelin: two different receptors
  The most-compared pair in endocrine research supply act on different receptor families entirely. What that means, plus the 4.7× mass gap and the DAC question.
  6 min read